Rankings
▼
Calendar
CLDX Q4 2022 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+382.9% YoY
Gross Profit
-$21M
-1319.7% margin
Operating Income
-$28M
-1728.8% margin
Net Income
-$26M
-1642.1% margin
EPS (Diluted)
$-0.56
QoQ Revenue Growth
+296.3%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$353M
Total Liabilities
$27M
Stockholders' Equity
$326M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$334,000
+382.9%
Gross Profit
-$21M
-$14M
-48.4%
Operating Income
-$28M
-$20M
-37.1%
Net Income
-$26M
-$20M
-31.5%
Revenue Segments
Grant
$2M
98%
Service
$26,000
2%
← FY 2022
All Quarters
Q1 2023 →